Giuseppe V Masucci

9PUBLICATIONS
42CO-AUTHORS
Predictive and prognostic markersImmunogenetics (incl. genetic immunology)Radiation therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 21, 2023
Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer.

Bernhard Mlecnik, Alessandro Lugli, Gabriela Bindea

|Sep 23, 2022
Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study.

Bernhard Mlecnik, Toshihiko Torigoe, Gabriela Bindea

|May 31, 2022
Precision radiation of immune checkpoint therapy resistant melanoma metastases (PROMMEL study): study protocol for a phase II open-label multicenter trial.

Ellen Backlund, Muyi Yang, Vitali Grozman

|Aug 27, 2021
Clinical Categorization Algorithm (CLICAL) and Machine Learning Approach (SRF-CLICAL) to Predict Clinical Benefit to Immunotherapy in Metastatic Melanoma Patients: Real-World Evidence from the Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.

Gabriele Madonna, Giuseppe V Masucci, Mariaelena Capone

|Jan 15, 2021
Sex Differences in Overall Survival and the Effect of Radiotherapy in Merkel Cell Carcinoma-A Retrospective Analysis of a Swedish Cohort.

Hannah Björn Andtback, Viveca Björnhagen-Säfwenberg, Hao Shi

|Nov 06, 2020
Prognostic Interactions between FAP+ Fibroblasts and CD8a+ T Cells in Colon Cancer.

Mercedes Herrera, Artur Mezheyeuski, Lisa Villabona

Pageof 2

Frequent Collaborators

3 joint publications

Rolf Kiessling

2 joint publications

SeongJun Han

2 joint publications

Stina Wickström

2 joint publications

Andreas Lundqvist